Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

IOC reassures anxious Japan that Olympics will be safe

Published 05/18/2021, 10:59 PM
Updated 05/19/2021, 10:26 PM
© Reuters. FILE PHOTO: Security personnel stand guard near the Olympic rings monument during a rally by anti-Olympics protesters outside the Japanese Olympic Committee headquarters, amid the coronavirus disease (COVID-19) outbreak, in Tokyo, Japan May 18, 2021. REUT

(This story corrects second paragraph to clarify that IOC President Thomas Bach was speaking via videoconference and was not in Tokyo)

By Rocky Swift

TOKYO (Reuters) - The International Olympic Committee (IOC) reassured an anxious Japan on Wednesday that the Tokyo Olympics would be safe for athletes as well as the host community, amid mounting opposition to the Games and fears it will fuel a spike in COVID-19 cases.

Speaking via videoconference that was broadcast alongside senior Japanese officials in Tokyo, IOC chief Thomas Bach said he believed more than 80% of residents of the Olympic Village would be vaccinated or booked for vaccination ahead of the Games set to start on July 23.

He rejected growing calls to cancel the global sporting showpiece, already delayed once due to the pandemic, saying that other sporting events had proved the Olympics could go ahead with strong COVID precautions.

Bach's comments came as Japan kept up its battle on a fourth wave of infections, although a slow vaccination campaign has undermined already shaky public confidence that the Games should proceed.

"Together with our Japanese partners and friends, I can only re-emphasise this full commitment of the IOC to organise safe Olympic and Paralympic games for everybody," Bach said.

"To accomplish this, we are now fully focused on the delivery of the Olympic Games."

Less than 30% of medics in Japan's major cities have been vaccinated against the coronavirus, with just 65 days left to the start of the Olympics, the Nikkei newspaper said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cabinet figures showed this week that three months into Japan's vaccination push, less than 40% of its medical workers were fully inoculated.

The problem is especially pronounced in the capital, Tokyo, which plays host to the Games, and other large population centres, where the rate of fully vaccinated medical workers was less than 30%, the Nikkei added.

Much of the vaccine supply was concentrated in large hospitals, and there had been problems in the reservation systems for medical staff, it said.

The slow pace of vaccinations of doctors and nurses has been among the complaints cited by medical groups that oppose the Games.

Requests for about 200 doctors and 500 nurses to help out with the Games are unrealistic, said Kenyu Sumie, the chairman of a group representing more than 100,000 doctors and dentists in Japan.

"It's impossible to think about dispatching them (to the Olympics) when they haven't even received their own two shots," Sumie told Reuters on Wednesday. "There is no way that the Olympics can be safely held at this point."

Bach said the IOC would do its part to keep the Japanese public safe, by having additional medical personnel as part of the NOC delegations to support the medical operations and the strict implementation of the COVID 19 countermeasures.

STATES OF EMERGENCY

Much of Japan, including the key cities of Tokyo and Osaka, is under a state of emergency until month-end to rein in infections. The southern prefecture of Okinawa will request its own emergency declaration as new infections reached record highs, it said on Wednesday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Japan aims to inoculate most of its 36 million people older than 65 by the end of July. To reach that target, it hopes to deliver about a million shots a day, or three times faster than the current pace.

So far, just 3.7% of the population of 126 million have received at least one vaccine shot, the lowest rate among wealthy countries. Initially, the holdup was scant supplies of the vaccine developed by Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), the only one approved by regulators.

But arrivals of the Pfizer vaccine have increased dramatically in May, and Japan is expected to approve Moderna (NASDAQ:MRNA) Inc's candidate this week for use in mass vaccination centres. The shot developed by AstraZeneca (NASDAQ:AZN) PLC is also being considered by domestic regulators.

As supply bottlenecks eased, problems with vaccine reservation systems and manpower shortages have cropped up. The government is looking into letting pharmacists give the injections, after a similar move regarding dentists last month.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.